Conversely, PARK2 is a susceptibility gene for leprosy (Mira et al. 2004), and de Léséleuc et al. (2013) have reported that polymorphisms mapping to the PARK2 promoter region could also exert some regulator effect in trans on the secretion of inflammatory cytokines. The gene discussed is PRKN; the disease is leprosy.